imipenem brands
1 registered brand containing imipenem in Rwanda.
imipenem
PubChem CID 104838Molecular formula: C12H17N3O4S
Imipenem acts as an antimicrobial through the inhibition of cell wall synthesis of various gram-positive and gram-negative bacteria. This inhibition of cell wall synthesis in gram-negative bateria is attained by binding to penicillin-binding proteins (PBPs). In E. coli and selected strains of P. aeruginosa, imipenem has shown to have the highest affinity to PBP-2, PBP-1a, and PBP-1b. This inhibition of PBPs prevents the bacterial cell from adding to the peptidoglycan polymer which forms the bacterial cell wall eventually leading to cell death.
peptidoglycan biosynthesis V (β-lactam resistance)BioCyc
peptidoglycan maturation (meso-diaminopimelate containing)BioCyc
peptidoglycan maturation (meso-diaminopimelate containing)BioCyc
Source: PubChem (NCBI) · compound 104838
All countries
Kenya
Tanzania
Rwanda
Zambia
Uganda
Malawi
South Africa
Zimbabwe
Nigeria
Ghana
Botswana
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| IMPLATINZE 500MG/500MG Powder for Solution for IV Infusion |
Pharco B | Registered | Rwanda |